In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer
Biotechnology Notes · 2026 · 7 · 156-167
DOI: 10.1016/j.biotno.2026.06.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Notes, 2026. Verfasst von Mala M Parab und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Bioinformatics, D Y Patil Deemed to Be University, Navi Mumbai, 400614, Maharashtra, India. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biotechnology and Bioinformatics, D Y Patil Deemed to Be University, Navi Mumbai, 400614, Maharashtra, India.
- MET Institute of Pharmacy, MET, Nashik, Maharashtra, India.
Zitieren
APA
Parab, M. M., Gupta, P. P., Shetty, S., Chhajed, S. S., Shukla, G., Bapat, K., Dasgupta, D., & Boruah, P. (2026). In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. Biotechnology Notes, 7, 156-167. https://doi.org/10.1016/j.biotno.2026.06.002
Vancouver
Parab MM, Gupta PP, Shetty S, Chhajed SS, Shukla G, Bapat K, et al. In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. Biotechnology Notes. 2026;7:156-167. doi:10.1016/j.biotno.2026.06.002
BibTeX
@article{Parab2026,
author = {Parab, Mala M and Gupta, Pramodkumar P and Shetty, Shraddha and Chhajed, Santosh S and Shukla, Geetanjali and Bapat, Kshitij and Dasgupta, Debjani and Boruah, Prerona},
title = {In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer},
journal = {Biotechnology Notes},
year = {2026},
volume = {7},
pages = {156--167},
doi = {10.1016/j.biotno.2026.06.002}
}
EUVIMED